JENNIFER HENDERSON: Open Payments
NPI 1548561871 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,137 in 223 payments from 21 companies in 2025. Trend: 2023 $4,019 · 2024 $4,461 · 2025 $4,137
Food & beverage: $4,021Education: $116
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $612 |
| ABBVIE INC. | 35 | $550 |
| LEO Pharma Inc. | 26 | $399 |
| Incyte Corporation | 15 | $289 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $278 |
| Arcutis Biotherapeutics, Inc. | 15 | $271 |
| Novartis Pharmaceuticals Corporation | 11 | $268 |
| Regeneron Healthcare Solutions, Inc. | 10 | $258 |
| Amgen Inc. | 23 | $251 |
| Lilly USA, LLC | 10 | $181 |
Products named: TREMFYA, DUPIXENT, ADBRY, RINVOQ, OPZELURA, Zoryve, OTEZLA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
